Aortic Mitral Articles & Analysis
4 news found
“Currently, there are no transfemoral TAVR devices approved for aortic regurgitation in China; however, some patients with severe aortic regurgitation have to be treated by off-label use of TAVR devices as they are not eligible for open-heart surgery. ...
The teams will collaborate to develop several case-specific 3D-printed models of mitral and aortic valves that they will use to simulate patient-specific procedures ahead of the real-life case to validate the training solution. ...
ByBIOMODEX
Neuchâtel, Switzerland, February 22, 2019 – Novostia announces that it raised CHF 6.5 million from private investors to advance its disruptive aortic and mitral heart valve to clinical trials. Heart valve diseases affect more than 100 million people worldwide. ...
The addition of a self-expanding program positions Colibri to be the only company with both intellectual property and technology to develop pre-packaged, ready-for-use, balloon and self-expanding transcatheter heart valve technology for aortic, mitral, and pulmonary applications. About the Colibri Heart Valve and the Ready-to-Use Colibri TAVI System Colibri ...